View in EDS HTML Full Text PDF Full Text

Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta.

Saved in:
Bibliographic Details
Title: Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta.
Authors: Lampertico P; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; CRC 'A. M. And A. Migliavacca' Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Bogomolov PO; State Budgetary Institution of Health Care of Moscow Region, Moscow Regional Research Clinical Institute n.a. M.F. Vladimirsky, Moscow, Moscow, Russian Federation., Chulanov V; National Medical Research Center of Tuberculosis and Infectious Diseases, Moscow, Russian Federation.; Sechenov First Moscow State Medical University, Moscow, Russian Federation., Stepanova T; Limited Liability Company 'Clinic of Modern Medicine,' Moscow, Moscow, Russian Federation., Morozov V; LLC Medical Company Hepatolog, Samara, Russian Federation., Allweiss L; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems, Borstel, Germany., Dandri M; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems, Borstel, Germany., Burhenne J; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.; German Center for Infection Research (DZIF), Heidelberg, Germany., Blank A; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.; German Center for Infection Research (DZIF), Heidelberg, Germany., Ciesek S; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.; German Centre for Infection Research, External Partner Site, Frankfurt, Germany., Elsner C; Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Dittmer U; Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., An Q; Gilead Sciences Inc., Foster City, California, USA., Manuilov D; Gilead Sciences Inc., Foster City, California, USA., Da BL; Gilead Sciences Inc., Foster City, California, USA., Flaherty JF; Gilead Sciences Inc., Foster City, California, USA., Urban S; German Center for Infection Research (DZIF), Heidelberg, Germany.; Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital, Heidelberg, Germany., Wedemeyer H; Department of Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Braunschweig, Germany.; Excellence Cluster RESIST and D-Solve Consortium, Hannover, Germany.
Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2025 Feb; Vol. 45 (2), pp. e70008.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39853842
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lampertico+P%22">Lampertico P</searchLink>; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; CRC 'A. M. And A. Migliavacca' Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bogomolov+PO%22">Bogomolov PO</searchLink>; State Budgetary Institution of Health Care of Moscow Region, Moscow Regional Research Clinical Institute n.a. M.F. Vladimirsky, Moscow, Moscow, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Chulanov+V%22">Chulanov V</searchLink>; National Medical Research Center of Tuberculosis and Infectious Diseases, Moscow, Russian Federation.; Sechenov First Moscow State Medical University, Moscow, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Stepanova+T%22">Stepanova T</searchLink>; Limited Liability Company 'Clinic of Modern Medicine,' Moscow, Moscow, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Morozov+V%22">Morozov V</searchLink>; LLC Medical Company Hepatolog, Samara, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Allweiss+L%22">Allweiss L</searchLink>; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.<br /><searchLink fieldCode="AU" term="%22Dandri+M%22">Dandri M</searchLink>; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.<br /><searchLink fieldCode="AU" term="%22Burhenne+J%22">Burhenne J</searchLink>; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.; German Center for Infection Research (DZIF), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Blank+A%22">Blank A</searchLink>; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.; German Center for Infection Research (DZIF), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Ciesek+S%22">Ciesek S</searchLink>; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.; German Centre for Infection Research, External Partner Site, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Elsner+C%22">Elsner C</searchLink>; Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Dittmer+U%22">Dittmer U</searchLink>; Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22An+Q%22">An Q</searchLink>; Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Manuilov+D%22">Manuilov D</searchLink>; Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Da+BL%22">Da BL</searchLink>; Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Flaherty+JF%22">Flaherty JF</searchLink>; Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Urban+S%22">Urban S</searchLink>; German Center for Infection Research (DZIF), Heidelberg, Germany.; Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wedemeyer+H%22">Wedemeyer H</searchLink>; Department of Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Braunschweig, Germany.; Excellence Cluster RESIST and D-Solve Consortium, Hannover, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101160857%22">Liver international : official journal of the International Association for the Study of the Liver</searchLink> [Liver Int] 2025 Feb; Vol. 45 (2), pp. e70008.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101160857 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1478-3231 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214783223%22">14783223 </searchLink><i>NLM ISO Abbreviation: </i>Liver Int <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39853842
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/liv.70008
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70008
    Titles:
      – TitleFull: Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lampertico P
      – PersonEntity:
          Name:
            NameFull: Bogomolov PO
      – PersonEntity:
          Name:
            NameFull: Chulanov V
      – PersonEntity:
          Name:
            NameFull: Stepanova T
      – PersonEntity:
          Name:
            NameFull: Morozov V
      – PersonEntity:
          Name:
            NameFull: Allweiss L
      – PersonEntity:
          Name:
            NameFull: Dandri M
      – PersonEntity:
          Name:
            NameFull: Burhenne J
      – PersonEntity:
          Name:
            NameFull: Blank A
      – PersonEntity:
          Name:
            NameFull: Ciesek S
      – PersonEntity:
          Name:
            NameFull: Elsner C
      – PersonEntity:
          Name:
            NameFull: Dittmer U
      – PersonEntity:
          Name:
            NameFull: An Q
      – PersonEntity:
          Name:
            NameFull: Manuilov D
      – PersonEntity:
          Name:
            NameFull: Da BL
      – PersonEntity:
          Name:
            NameFull: Flaherty JF
      – PersonEntity:
          Name:
            NameFull: Urban S
      – PersonEntity:
          Name:
            NameFull: Wedemeyer H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1478-3231
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Liver international : official journal of the International Association for the Study of the Liver
              Type: main
ResultId 1